Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models.

Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models.

Show other versions (1)

Quantitation of bacterial load in tissues is essential for experimental investigation of Mycobacterium tuberculosis infection and immunity. We have used an automated liquid culture system to determine the number of colony forming units (CFU) in murine tissues and compared the results to those obtain...

ver descrição completa

Detalhes bibliográficos
Main Authors:	O'Sullivan, D, Sander, C, Shorten, R, Gillespie, S, Hill, A, McHugh, T, McShane, H, Tchilian, E
Formato:	Journal article
Idioma:	English
Publicado em:	2007

Registos relacionados

Evaluation of liquid culture for quantitation of Mycobacterium tuberculosis in murine models.
Por: O'Sullivan, D, et al.
Publicado em: (2007)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
Por: Tchilian, E, et al.
Publicado em: (2009)

Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis
Por: Tchilian, E, et al.
Publicado em: (2011)

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant Delta ureC hly(+) Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis, (vol 77, pg 630, 2009)
Por: Tchilian, E, et al.
Publicado em: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
Por: Marsay, L, et al.
Publicado em: (2013)

A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.
Por: Beverley, P, et al.
Publicado em: (2014)

New tuberculosis vaccines can diminish as well as enhance BCG induced protection: Results from a murine model
Por: Sander, C, et al.
Publicado em: (2006)

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.
Por: Forbes, E, et al.
Publicado em: (2008)

Vaccines for tuberculosis
Por: McShane, H
Publicado em: (2013)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
Por: Marsay, L, et al.
Publicado em: (2013)

Human and Bovine Tuberculosis
Por: McShane, H
Publicado em: (2016)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
Por: Griffiths, K, et al.
Publicado em: (2013)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
Por: Griffiths, K, et al.
Publicado em: (2011)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel mycobacterium tuberculosis vaccine MVA85A
Por: Griffiths, K, et al.
Publicado em: (2011)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guérin
Por: Minassian, A, et al.
Publicado em: (2012)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
Por: Minassian, A, et al.
Publicado em: (2012)

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis.
Por: Murphy, M, et al.
Publicado em: (2017)

Insights and challenges in tuberculosis vaccine development
Por: McShane, H
Publicado em: (2019)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
Por: Sander, C, et al.
Publicado em: (2009)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
Por: Poyntz, H, et al.
Publicado em: (2014)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
Por: McShane, H
Publicado em: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
Por: McShane, H
Publicado em: (2011)

Tuberculosis vaccines: Progress and challenges
Por: Checkley, A, et al.
Publicado em: (2011)

Elevated IgG responses in infants are associated with reduced prevalence of Mycobacterium tuberculosis infection
Por: Logan, E, et al.
Publicado em: (2018)

Local pulmonary immunological biomarkers in tuberculosis
Por: Morrison, H, et al.
Publicado em: (2021)

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.
Por: Lalvani, A, et al.
Publicado em: (2001)

Controlled human infection models: is it really feasible to give people tuberculosis?
Por: McShane, H
Publicado em: (2020)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
Por: McShane, H
Publicado em: (2023)

High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease.
Por: Pathan, A, et al.
Publicado em: (2000)

Why don’t we have an effective tuberculosis vaccine yet?
Por: Davenne, T, et al.
Publicado em: (2016)

Challenges in developing a controlled human tuberculosis challenge model
Por: Jackson, S, et al.
Publicado em: (2022)

Quantitative association tests of immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.
Por: Wiart, A, et al.
Publicado em: (2004)

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
Por: Williams, A, et al.
Publicado em: (2005)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
Por: Satti, I, et al.
Publicado em: (2022)

Molecular genotyping of mycobacterium tuberculosis associated with extrapulmonary tuberculosis
Por: Ayub, Nur Izzah Farakhin
Publicado em: (2015)

Development of Tools to Quantitatively Probe Mycobacterium tuberculosis-induced Host Phagosomal and Signaling Responses
Por: Solomon, Sydney Leigh
Publicado em: (2023)

Clinical testing of tuberculosis vaccine candidates
Por: Hatherill, M, et al.
Publicado em: (2016)

CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages.
Por: Brookes, R, et al.
Publicado em: (2003)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
Por: Vordermeier, H, et al.
Publicado em: (2009)

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.
Por: Scriba, T, et al.
Publicado em: (2012)